2m 2m 2m 2m 2m 2m 2m
Gilead Sciences (GILD)
NASDAQ
$146.11-$0.02 (-0.01%)
Price as of Aug 21, 2026 7:56 PM EDT- $177.9BMarket Cap
- 30.63%1-Year Change
- Drug Manufacturers - GeneralIndustry
Gilead Sciences (GILD)
$146.11-$0.02 (-0.01%)
GILD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $146.12 | ||
Change | +$2.68 (+1.87%) | ||
Open | $144.52 | ||
High | $147.91 | ||
Low | $143.50 | ||
Previous Close | $143.44 | ||
Volume | 5,384,711 | ||
30-Day Average Volume | 6,576,242 | ||
1-Week Change | 5.61% | ||
1-Month Change | 12.16% | ||
1-Year Change | 30.63% | ||
3-Year Change | 112.37% | ||
5-Year Change | 142.10% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $49.4B | ||
Market Cap | $177.9B | ||
Enterprise Value | $200.9B | ||
Period: QTR TTM FY | |||
Revenue | $7.6B | ||
Net Income | -$10.5B | ||
Free Cash Flow | $3.4B | ||
EBIT | -$10.3B | ||
EBITDA | -$10.2B | ||
Net Working Capital | $2.9B | ||
EPS | -$8.45 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | 26 | ||
P/B | 15 | ||
P/E | -17 | ||
PEG | 0 | ||
Price/Free Cash Flow | 53 | ||
Price/Operating Cash Flow | 51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.24% | ||
Trailing Annual Dividend Yield | 2.20% | ||
Ex-Dividend Date | 09/15/2026 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 01/28/2013 | ||
Earnings & Revenue
Annual Dividend Yield